178 related articles for article (PubMed ID: 15205871)
21. The consequences of beer consumption in rats: acute anxiolytic and ataxic effects and withdrawal-induced anxiety.
Gallate JE; Morley KC; Ambermoon P; McGregor IS
Psychopharmacology (Berl); 2003 Feb; 166(1):51-60. PubMed ID: 12474111
[TBL] [Abstract][Full Text] [Related]
22. Anxiety conditioned to nicotine in the elevated plus-maze is time dependent.
Tucci S; Cheeta S; Genn RF; Seth P; File SE
Behav Pharmacol; 2002 Dec; 13(8):615-20. PubMed ID: 12478211
[TBL] [Abstract][Full Text] [Related]
23. CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour.
Rubino T; Guidali C; Vigano D; Realini N; Valenti M; Massi P; Parolaro D
Neuropharmacology; 2008 Jan; 54(1):151-60. PubMed ID: 17692344
[TBL] [Abstract][Full Text] [Related]
24. Psychopharmacological characterisation of the successive negative contrast effect in rats.
Phelps CE; Mitchell EN; Nutt DJ; Marston HM; Robinson ES
Psychopharmacology (Berl); 2015 Aug; 232(15):2697-709. PubMed ID: 25791190
[TBL] [Abstract][Full Text] [Related]
25. Corticotropin releasing factor antagonist, alpha-helical CRF(9-41), reverses nicotine-induced conditioned, but not unconditioned, anxiety.
Tucci S; Cheeta S; Seth P; File SE
Psychopharmacology (Berl); 2003 May; 167(3):251-6. PubMed ID: 12669178
[TBL] [Abstract][Full Text] [Related]
26. Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission.
Rey AA; Purrio M; Viveros MP; Lutz B
Neuropsychopharmacology; 2012 Nov; 37(12):2624-34. PubMed ID: 22850737
[TBL] [Abstract][Full Text] [Related]
27. Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands.
Hayase T; Yamamoto Y; Yamamoto K
Behav Pharmacol; 2005 Sep; 16(5-6):395-404. PubMed ID: 16148444
[TBL] [Abstract][Full Text] [Related]
28. Orexin-1 receptor antagonism fails to reduce anxiety-like behaviour in either plus-maze-naïve or plus-maze-experienced mice.
Rodgers RJ; Wright FL; Snow NF; Taylor LJ
Behav Brain Res; 2013 Apr; 243():213-9. PubMed ID: 23333844
[TBL] [Abstract][Full Text] [Related]
29. Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system.
Zarrindast MR; Sarahroodi S; Arzi A; Khodayar MJ; Taheri-Shalmani S; Rezayof A
Behav Pharmacol; 2008 Oct; 19(7):716-23. PubMed ID: 18797248
[TBL] [Abstract][Full Text] [Related]
30. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
Kõks S; Soosaar A; Võikar V; Bourin M; Vasar E
Neuropeptides; 1999 Feb; 33(1):63-9. PubMed ID: 10657473
[TBL] [Abstract][Full Text] [Related]
31. Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats.
O'Shea M; McGregor IS; Mallet PE
J Psychopharmacol; 2006 Sep; 20(5):611-21. PubMed ID: 16714325
[TBL] [Abstract][Full Text] [Related]
32. Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice.
Balerio GN; Aso E; Maldonado R
Psychopharmacology (Berl); 2005 Sep; 181(2):260-9. PubMed ID: 15778877
[TBL] [Abstract][Full Text] [Related]
33. The role of the hippocampus in mediating emotional responses to nicotine and cannabinoids: a possible neural substrate for functional interactions.
Viveros MP; Marco EM; Llorente R; Lamota L
Behav Pharmacol; 2007 Sep; 18(5-6):375-89. PubMed ID: 17762508
[TBL] [Abstract][Full Text] [Related]
34. Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal.
Irvine EE; Cheeta S; File SE
Pharmacol Biochem Behav; 2001 Feb; 68(2):319-25. PubMed ID: 11267637
[TBL] [Abstract][Full Text] [Related]
35. Chronic periadolescent cannabinoid treatment enhances adult hippocampal PSA-NCAM expression in male Wistar rats but only has marginal effects on anxiety, learning and memory.
Higuera-Matas A; Botreau F; Miguéns M; Del Olmo N; Borcel E; Pérez-Alvarez L; García-Lecumberri C; Ambrosio E
Pharmacol Biochem Behav; 2009 Oct; 93(4):482-90. PubMed ID: 19576923
[TBL] [Abstract][Full Text] [Related]
36. Anxiogenic effect of sleep deprivation in the elevated plus-maze test in mice.
Silva RH; Kameda SR; Carvalho RC; Takatsu-Coleman AL; Niigaki ST; Abílio VC; Tufik S; Frussa-Filho R
Psychopharmacology (Berl); 2004 Nov; 176(2):115-22. PubMed ID: 15160262
[TBL] [Abstract][Full Text] [Related]
37. Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors.
Hayase T
BMC Neurosci; 2013 Feb; 14():20. PubMed ID: 23394117
[TBL] [Abstract][Full Text] [Related]
38. [Functional role of the endocannabinoid system in emotional homeostasis].
Marco EM; Viveros MP
Rev Neurol; 2009 Jan 1-15; 48(1):20-6. PubMed ID: 19145562
[TBL] [Abstract][Full Text] [Related]
39. Evaluating Potential Anxiolytic Effects of Minor Cannabinoids and Terpenes After Acute and Chronic Oral Administration in Rats.
Jenkins BW; Moore CF; Covey D; McDonald JD; Lefever TW; Bonn-Miller MO; Weerts EM
Cannabis Cannabinoid Res; 2023 Sep; 8(S1):S11-S24. PubMed ID: 37721993
[No Abstract] [Full Text] [Related]
40. Effects of Δ
Iglesias LP; Bedeschi L; Aguiar DC; Asth L; Moreira FA
Cannabis Cannabinoid Res; 2023 Feb; 8(1):24-33. PubMed ID: 35984927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
